A frequently raised question by addiction medicine practitioners around the world is that how recent advancements in different fields of Brain and Cognition Studies (BCS) - from molecular neuroscience to cognitive science - can help them improve their daily practice in prevention, treatment and rehabilitation of addictive disorders. Indeed, although there is a significant body of evidence from BCS about substance use and non-substance-related addictive disorders, the impact of this evidence on the daily practice of addiction medicine is minimal and yet to be established. The Neuroscience Interest Group of the International Society for Addiction Medicine (ISAM-NIG) believes that we need an orchestrated international effort to bring together pieces of basic and clinical evidence from BCS in order to develop a roadmap from bench to bedside and policy. We also need consensus and guidelines on how to bring currently available evidence to different dimensions of clinical practices ranging from prevention to recovery.
This crosscutting Research Topic between Frontiers in Psychiatry and Frontiers in Human Neuroscience welcomes researchers across the globe to submit their abstracts for original articles and reviews addressing this pathway. Any piece of empirical evidence or evidence-based synthesis from the BCS fields, including neuroscience, cognitive psychology, psychiatry, neurology, linguistics, artificial intelligence, education, and anthropology amongst many other disciplines with a potential added impact on the clinical practice of addiction medicine is welcome. For review papers, we encourage proposals including co-authors with different professional profiles/activities (e.g., researchers AND clinicians) to stimulate the translational roadmap and make sure that the final manuscript will provide a feasible path to translation and implementation. We suggest authors to also submit their abstracts to the
ISAM2018 meeting in 3-6 November in Busan, South Korea, as well, but abstract submission and participation in the ISAM meeting is not a requirement.
A frequently raised question by addiction medicine practitioners around the world is that how recent advancements in different fields of Brain and Cognition Studies (BCS) - from molecular neuroscience to cognitive science - can help them improve their daily practice in prevention, treatment and rehabilitation of addictive disorders. Indeed, although there is a significant body of evidence from BCS about substance use and non-substance-related addictive disorders, the impact of this evidence on the daily practice of addiction medicine is minimal and yet to be established. The Neuroscience Interest Group of the International Society for Addiction Medicine (ISAM-NIG) believes that we need an orchestrated international effort to bring together pieces of basic and clinical evidence from BCS in order to develop a roadmap from bench to bedside and policy. We also need consensus and guidelines on how to bring currently available evidence to different dimensions of clinical practices ranging from prevention to recovery.
This crosscutting Research Topic between Frontiers in Psychiatry and Frontiers in Human Neuroscience welcomes researchers across the globe to submit their abstracts for original articles and reviews addressing this pathway. Any piece of empirical evidence or evidence-based synthesis from the BCS fields, including neuroscience, cognitive psychology, psychiatry, neurology, linguistics, artificial intelligence, education, and anthropology amongst many other disciplines with a potential added impact on the clinical practice of addiction medicine is welcome. For review papers, we encourage proposals including co-authors with different professional profiles/activities (e.g., researchers AND clinicians) to stimulate the translational roadmap and make sure that the final manuscript will provide a feasible path to translation and implementation. We suggest authors to also submit their abstracts to the
ISAM2018 meeting in 3-6 November in Busan, South Korea, as well, but abstract submission and participation in the ISAM meeting is not a requirement.